-
Gastrodin, AT1 Signaling, and Reactive Astrocytes
2026-09-21
The 2024 study by Zuo and colleagues shows that inflammatory signals from activated microglia can engage a renin–angiotensin system–SIRT3 program in reactive astrocytes. By combining gastrodin treatment with AT1 inhibition, the work connects microglial conditioning to astrocyte inflammatory, phenotypic, and neurotrophic responses while also revealing limits of marker-based interpretation.
-
Prestained Protein Marker: Practical SDS-PAGE Guide
2026-09-20
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides visible size references for monitoring SDS-PAGE separation and checking protein transfer during Western blotting. It is intended for electrophoresis, membrane-transfer, and compatible fluorescent imaging workflows, but it should not be treated as a substitute for an assay-specific quantitative calibration standard.
-
Praeruptorin A Inhibits NF-κB in RAW264.7 Cells
2026-09-19
The reference study shows that praeruptorin A suppresses poly(I:C)-induced inflammatory signaling in RAW264.7 macrophages, combining RNA sequencing with molecular validation to connect transcriptional changes to NF-κB inhibition. Its findings define a concentration-conscious in vitro framework for studying TLR3-linked inflammation while highlighting limits for translation beyond macrophage models.
-
Deracoxib in TLR3-Informed Inflammation Assays
2026-09-19
Deracoxib is a selective COX-2 inhibitor that can help separate prostaglandin control from upstream innate-immune signaling. This guide translates a TLR3 macrophage study into practical assay decisions for pain, inflammation, and canine cancer biology research.
-
Bifendate, Autophagy, and Lipid Droplet Accumulation
2026-09-18
The reference study shows that bifendate inhibits autophagy at several discrete stages, including autophagosome–lysosome fusion, lysosome acidification, and autophagic lysosome reformation. It also reports reduced oleic acid-induced lipid droplet accumulation, providing a mechanistic framework for interpreting bifendate activity in cellular models of hepatic lipid stress.
-
Alda 1: Reliable ALDH2 Assay Workflows
2026-09-17
A scenario-based guide to using Alda 1 (SKU B5508) in ALDH2, cell viability, proliferation, cytotoxicity, and cardiac stress experiments. It connects genotype-aware interpretation with practical handling, controls, assay optimization, and evidence limits.
-
Angiotensin II: From Receptor Signal to Vascular Assay
2026-09-17
Angiotensin II research often stops at vasoconstriction; this guide connects receptor-proximal signaling with endothelial redox, nitric oxide, and vascular remodeling readouts. It also translates a recent HUVEC study into practical assay-design decisions for the Asp-Arg-Val-Tyr-Ile-His-Pro-Phe peptide.
-
ALDH2, Cardiomyocyte Proliferation, and Heart Failure
2026-09-17
A 2025 Experimental Cell Research study identifies ALDH2 as a regulator of cardiomyocyte proliferation, extending its role beyond oxidative-stress control and aldehyde detoxification. In neonatal mice and a transverse aortic constriction model, pharmacological ALDH2 activation increased cardiomyocyte proliferation and delayed pressure overload-induced heart failure, providing a mechanistic framework for cardiac regeneration research.
-
(S)-(+)-Methoprene: Assay Workflow
2026-09-16
This scenario-based guide explains how (S)-(+)-Methoprene, SKU C3249, can improve experimental interpretation in juvenile hormone, receptor, developmental, and cell-based research. It covers biological scope, solvent compatibility, solution stability, orthogonal readouts, and practical vendor-selection criteria.
-
Berbamine Hydrochloride: NF-κB to Ferroptosis
2026-09-15
Berbamine hydrochloride offers a strategically useful research probe for connecting NF-κB, STAT3, calcium homeostasis, and ferroptosis biology. This article translates recent findings on the METTL16–SENP3–LTF axis into a disciplined experimental framework for leukemia and hepatocellular carcinoma models while distinguishing established evidence from testable hypotheses.
-
Deracoxib: From COX-2 Biology to Translational Design
2026-09-15
A translational perspective on Deracoxib that connects selective COX-2 biology with canine inflammation, osteosarcoma models, assay design, exposure constraints, and evidence-led cancer research strategy.
-
Dexamethasone: Applied Workflow Guide
2026-09-14
Dexamethasone (DHAP) is a versatile glucocorticoid anti-inflammatory reagent for modeling NF-κB regulation, stem-cell differentiation, osteosarcoma growth, and neuroinflammation. This practical guide connects assay design, formulation, timing, controls, and troubleshooting to help researchers obtain interpretable, reproducible results.
-
NEDD4L–PRMT5 Axis in Colorectal Cancer Metastasis
2026-09-14
The 2025 Advanced Science study identifies the HECT E3 ligase NEDD4L as a suppressor of colorectal cancer liver metastasis through targeted degradation of PRMT5. Its in vivo screening and mechanistic validation connect NEDD4L-dependent PRMT5 turnover with reduced AKT1 arginine methylation, AKT/mTOR signaling, tumor-cell proliferation, and metastatic colonization.
-
Dihydrotestosterone: Practical Signaling Workflows
2026-09-13
Dihydrotestosterone (DHT) enables controlled interrogation of androgen receptor signaling in bladder cancer and muscle-focused disease models. This guide translates product specifications and pathway evidence into executable dosing, control, troubleshooting, and assay-design strategies.
-
Losartan in Podocyte and Vascular Research
2026-09-12
Losartan is an angiotensin II receptor antagonist that can anchor mechanistic studies spanning vascular remodeling and diabetic kidney disease. This article explains how to use it as an AT1-pathway comparator alongside the FGF4-FGFR1 podocyte-survival axis, with practical assay-design guidance.